F.D.A. Approves a New Drug for Advanced Breast Cancer

Patient Resources

The Food and Drug Administration approved a new type of drug that combines the widely used breast cancer medicine Herceptin with a powerful toxin to more effectively kill cancer cells while potentially reducing side effects.  The drug, which will be called Kadcyla but...

Inflammatory Breast Cancer: What You Should Know

Patient Resources, Physician Resources

From Medscape News: Inflammatory breast cancer (IBC) accounts for 1%-5% of all breast cancer cases but 10% of breast cancer deaths. Historically, 5-year survival in IBC has been less than 5% when treated with surgery or radiation therapy, increasing to 30%-40% with...

World Cancer Day – Myths about Cancer Day

General

World Cancer Day… A day set aside to dispel damaging myths and misconceptions about cancer…so let’s start with common breast cancer myths as they might relate to Inflammatory Breast Cancer, IBC, the most fatal of all the breast cancers.  This...

Lori Grennan Passes Away

General

  “The IBC world suffered a great loss today. Lori Grennan, the inspiration for much of our work, has passed away. Peace to her family and all who loved her. We will continue on, in her honor, educating and funding IBC research. Hope always, from one who...

Morgan Welch Inflammatory Breast Cancer

General, Physician Resources

Inflammatory Breast Cancer Research Program Inflammatory breast cancer is a rare form of breast cancer which accounts for only 2% to 6% of all cases of breast cancers, but it is a highly aggressive disease with a poor prognosis (5 year survival rate of 40%)....